Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
Rethinking the use of oral agents in the treatment of type 2 diabetes mellitus
Philip Raskin
Internal Medicine
Inl Med - Endcrn Diabetes Clin
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Rethinking the use of oral agents in the treatment of type 2 diabetes mellitus'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Blood Glucose
19%
Clinical Studies
32%
Diabetes Complications
23%
Double-Blind Method
22%
Eating
17%
Glucose
14%
Hyperglycemia
21%
Hypoglycemic Agents
44%
Information Storage and Retrieval
21%
Insulin
31%
Insulin Secretion
22%
Language
18%
Liver
11%
MEDLINE
20%
Morbidity
27%
Mortality
23%
Nervous System
18%
Publications
19%
Skeletal Muscle
18%
Therapeutics
15%
Type 2 Diabetes Mellitus
69%
Vascular Resistance
21%
Chemical Compounds
Food
21%
Glucose
45%
Glycemic
48%
Insulin Derivative
94%
Oral Antidiabetic Agent
100%
Resistance
19%